| Literature DB >> 34177267 |
Wendie Zhou1,2, Suebsarn Ruksakulpiwat3, Lingling Ji4, Yuying Fan1,2.
Abstract
BACKGROUND: Poor physical functioning (PF) is a common issue among critically ill patients. It was suggested that reasonable nutrition accelerates PF recovery. However, the details and types of nutritional interventions on the PF of different intensive care unit (ICU) patients at present have not been well analyzed yet. This study aimed to systematically synthesize nutritional interventions on PF in different ICU populations.Entities:
Keywords: intensive care units; nutrition; physical functioning
Year: 2021 PMID: 34177267 PMCID: PMC8219235 DOI: 10.2147/JMDH.S314132
Source DB: PubMed Journal: J Multidiscip Healthc ISSN: 1178-2390
Inclusion and Exclusion Criteria
| Inclusion Criteria | Exclusion Criteria |
|---|---|
Human patients ≥18 years of age | Conference proceedings, dissertations, commentaries, non-peer reviewed journal articles, research protocols, pilot studies, case reports, reviews (except systematic reviews and meta-analyses) |
Patients receiving treatment in the ICU | Combined with other types of interventions (eg, exercise, electrical stimulation) |
Featured a nutritional intervention, which is defined in this study as 1) route of administration: enteral nutrition, parenteral nutrition; 2) the administration of non-pharmacological/non-immune-modulating agents: calories, protein, micronutrients, micronutrients etc.; 3) timing for initiation of feeding; 4) continuous or intermittent feeding; and 5) feeding speed and amount | Exploring the effects of any of 1) pharmacological agents: insulin, growth hormone, ghrelin agonists, anabolic steroids etc.; 2) immune-modulating agents: glutamine, selenium, fish oil, zinc, vitamin D etc.; 3) antioxidants: vitamin C, vitamin E etc.; and 4) monitoring/management of nutritional effects: GRV, gastrointestinal syndrome (diarrhea, abdominal distension, abdominal pain, nausea or vomiting, etc.), blood electrolytes (potassium, magnesium etc.) etc. |
Reported a physical functioning outcome, including muscle mass, muscle strength (eg, muscle wasting, muscle weakness, fatigue, hand grip etc.), function (eg, walk, daily living tasks, etc.) | |
Reported in English language |
Abbreviations: ICU, intensive care unit; GRV, gastric residual volume.
Figure 1PRISMA flow chart. *Original Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients (EPaNIC) study and four sub-analyses of it were treated as one EPaNIC study. Notes: PRISMA figure adapted from Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology. 2009;62(10). Creative Commons.31
The Characteristics of Included Studies
| Characteristic | Number | Percentage (%) |
|---|---|---|
| Publication year | ||
| 2015–2020 | 10 | 83.33 |
| 2010–2014 | 2 | 16.76 |
| Country of origin | ||
| Australia | 4 | 30.77 |
| New Zealand | 1 | 7.69 |
| Belgium | 1 | 7.69 |
| Japan | 1 | 7.69 |
| United States | 1 | 7.69 |
| Denmark | 1 | 7.69 |
| United Kingdom | 1 | 7.69 |
| China | 1 | 7.69 |
| N/A | 2 | 15.38 |
| Location of study | ||
| Single-center | 5 | 41.67 |
| Multi-center | 5 | 41.67 |
| N/A | 2 | 16.66 |
| Study design | ||
| RCT | 6 | 50.00 |
| Descriptive study* | 3 | 25.00 |
| Systematic review | 2 | 16.67 |
| Non-randomized control trial | 1 | 8.33 |
| Sample size | ||
| 0–100(39) | 3 | 25.00 |
| >100–200 | 4 | 33.33 |
| >200–1000 | 1 | 8.33 |
| >1000 | 2 | 16.67 |
| N/A | 2 | 16.67 |
| Commenced time | ||
| Within 24 hours after ICU admission | 3 | 23.08 |
| Within 48 hours after ICU admission | 3 | 23.08 |
| Within 72 hours after ICU admission | 2 | 15.38 |
| Unspecified | 3 | 23.08 |
| Others | 2 | 15.38 |
| Target ICU population | ||
| Mechanically ventilated** | 6 | 50.00 |
| Chronic critical illness | 1 | 8.33 |
| Relative contraindications to early enteral nutrition (EN) | 1 | 8.33 |
| A requirement of parenteral nutrition (PN) | 1 | 8.33 |
| ALL*** | 3 | 25.00 |
| Nutritional intervention type | ||
| Early PN | 2 | 16.67 |
| Early EN | 1 | 8.33 |
| Early goal-directed nutrition (EGDN) | 1 | 8.33 |
| Early adequate nutrition | 1 | 8.33 |
| Higher protein delivery | 1 | 8.33 |
| Higher energy delivery | 1 | 8.33 |
| Low energy delivery | 2 | 16.67 |
| Energy and protein delivery | 1 | 8.33 |
| Intermittent enteral feeding | 1 | 8.33 |
| N/A | 1 | 8.33 |
| Physical functioning measure(s) | ||
| Function | 12/1# | 54.55/8.33## |
| Muscle strength | 6/3$ | 27.27/50.00$ |
| Muscle mass | 4/1& | 18.18/25.00&& |
| LOE | ||
| I | 2 | 16.67 |
| II | 6 | 50.00 |
| III | 1 | 8.33 |
| VI | 3 | 25.00 |
Notes: *Descriptive study consists of prospective and retrospective studies. **Mechanically ventilated consists of mechanically ventilated and expected to receive enteral nutrition for at least 2 days/acutely admitted/with sepsis/ with multiorgan failure/for at least 48 hours/ for at least 24 hours. ***ALL means that all ICU patient was qualified to enroll in a study. #Total function outcome measure (n)/total function outcome measure improved (n). ##Total function outcome measure (%)/total function outcome measure improved (%). $Total muscle strength outcome measure (n)/total muscle strength outcome measure improved (n). $Total muscle strength outcome measure (%)/total muscle strength outcome measure improved (%). &Total muscle mass outcome measure (n)/total muscle mass outcome measure improved (n). &&Total muscle mass outcome measure (%)/total muscle mass outcome measure improved (%).
Abbreviations: N/A, not applicable (systematic reviews/meta-analyses); RCT, randomized control trial; ICU, intensive care unit; LOE, level of evidence.
Summary of Included Studies
| Study, Duration | Design, Sample (n), Commenced Time, Provider(s) | Target ICU Population | Description of Intervention | Physical Functioning Measure(s) | Finding(s) | LOE |
|---|---|---|---|---|---|---|
| 1) Casaer, | Multi-center | All | - Experimental group: early parenteral nutrition (PN): PN initiated within 48 hours after ICU admission. The target for total energy intake was 400 kcal per day on ICU day 1 and 800 kcal per day on day 2. On day 3, parenteral nutrition was initiated, with the dose targeted to 100% of the caloric goal through combined enteral and parenteral nutrition. Caloric needs calculations are based on corrected ideal body weight, age and gender. The maximum caloric goal for all patients was 2880 kcal per day. A protocol for the early initiation of enteral nutrition was applied to both groups, and insulin was infused to achieve normoglycemia. | Function (walk, daily living tasks), muscle mass (muscle loss, myofiber integrity, muscle atrophy), muscle strength (muscle weakness) | 1) Distance on 6-min walk test - ≠ (n = 4640) | II |
| 2) Doig et al | Multi-center | Relative contraindications to early enteral nutrition (EN) | - Experimental group: early PN: provide parenteral nutrition within 24 hours of ICU admission from a ready-to-mix 3-chamber bag, with starting rates and rate increases defined by study protocol and trace elements, minerals, and vitamins added as clinically appropriate. Targets were to be achieved by study day 3. The protocol reminded clinicians to consider additional vitamins and minerals on each study day and to consider enteral or oral nutrition on study day 3. The protocol also defined timing and rates for parenteral nutrition discontinuation. Energy targets were calculated using the Harris-Benedict equation, allowing for stress factors. Targets were capped at 35 kcal/kg/d, and obese patients were fed to their ideal body weight (BMI=21). | Muscle strength (muscle wasting), function | 1) Subjective Global Assessment (SGA) of muscle wasting - ˄ | II |
| 3) Ferrie et al | Single-center | Requirement of PN and expected to receive PN for at least 3 days | - Experimental group: higher protein/amino acid provision: receive blinded PN solutions containing amino acids at 1.2 g/kg. Target infusion rate was set at 0.92 mL/h per kg body weight, aiming to supply daily energy at 24 kcal/kg. | Muscle strength (hand grip, fatigue), muscle mass (muscle thickness) | 1) Grip strength at ICU discharge - ≠ | II |
| 4) Reid et al | Multi-center | Mechanically ventilated and expected to receive enteral nutrition for at least 2 days | - Experimental group: augmented early nutritional energy delivery: receive a 1.5-kcal/kg/h enteral nutrition solution for 10 days. Protein and fiber contents in the 2 groups were similar (protein: around 0.056 g/mL, fiber: around 0.015 g/mL). The study enteral nutrition was delivered at a goal rate of 1 mL • kg ideal body weight (IBW) 21−1 • h21−1 in both groups. | Function (mobility, daily living tasks) | 1) SF-36v2 physical function summary score - ≠ | II |
| 5) Allingstrup et al | Single-center | Mechanically ventilated (acutely admitted) | - Experimental group: early goal-directed nutrition (EGDN): measure nutritional requirements by indirect calorimetry (Quark | Function | 1) Physical component summary (PCS) score of the Medical Outcomes Study 36-item short form health survey at 6 months - ≠ | II |
| 6) Lambell et al | N/A (systematic review) | All | This systematic literature review was conducted to examine the association of energy and/or protein provision on changes in skeletal muscle mass in critically ill patients. Key databases were searched up until March 2016 to identify studies that measured skeletal muscle mass and/or total body protein (TBP) at 2 or more time points during acute critical illness (up to 2 weeks after an ICU stay). | Muscle mass | 1) The association between energy and protein delivery and changes in skeletal muscle mass - ≠ | I |
| 7) Liu et al | Single-center | Mechanically ventilated with sepsis | - Experimental group: early enteral nutrition (EN): receive enteral nutrition treatment within 48 hours of being admitted to ICU. The target calories and protein contents in this study were 25 kcal/kg/d (Ideal body weight) and 1.2 g/kg/d, respectively. The EN tolerance was assessed every day to gradually increase the dose to gain the goal of calorie 25–30 kcal/kg/d and protein content 1.2–2.0 g/kg/d. the Warming infusion of the nutrient solution was performed at uniform speed using the reverse Trendelenburg position. | Muscle strength (muscle weakness) | 1) Incidence of ICU-AW - ˄ | III |
| 8) Fetterplace et al | Single-center | Mechanically ventilated (for at least 48 hours) | In this prospective study, the cumulative energy deficit was determined from artificial nutrition delivery compared to targets. Measurements included: | Muscle strength (muscle weakness), function | 1) The association between cumulative energy deficit (per 1000 kcal) and greater odds of ICU-AW - ˄ | VI |
| 9) Taverny et al | N/A (systematic review) | All | This systematic literature review was conducted to describe the outcomes used in recent randomized controlled trials (RCTs) assessing nutritional interventions in critically ill patients. The objective was to set the foundation for the development of a core set of outcome measures for use in future RCTs. | Function (daily living tasks, upper limb function (dexterity), lower limb function (walking or mobility), spinal function, walking distance), muscle strength | 1) Physical function - ˅ | I |
| 10) Yatabe et al | Multi-center | Mechanically ventilated (for at least 24 hours) | This observational study aimed to assess the nutritional management in Japanese ICUs and investigate the impact of nutritional management and rehabilitation on the physical outcome (the author defined good physical status as more than end sitting and poor physical status as bed rest and sitting). Participants were divided the into 2 groups, the good physical status group (good group) and poor physical status group (poor group) for analysis of the secondary outcome. | Function (more than sitting) | 1) The association between low caloric intake (less than 10 kcal/kg/day) until day 3 and good physical status - ˄ | VI |
| 11) McNelly et al | Multi-center | Mechanically ventilated with multiorgan failure | - Experimental group: intermittent enteral feeding: receive intermittent enteral feeding from six 4-hourly feeds per 24 hours, administered via nasogastric tube using a syringe over 3 to 5 min. Depending on each Trust’s approved supplier, either Ensure Compact (energy content, 2.4 kcal/mL; protein content, 0.104 g/mL; Abbott Nutrition) or Fortisip Compact Protein (energy content, 2.4 kcal/mL; protein content, 0.144 g/mL; Nutricia) was used, with a range of starter bolus sizes of 60 to 80 mL according to the participants’ initial individual nutritional targets (energy targets measured by the modified Penn State Equation; protein target at least 1.2 g/kg/day). | Muscle mass (muscle loss), function (sit-to-stand, bed-to-chair transfer) | 1) 10-day loss of rectus femoris muscle cross-sectional area determined by ultrasound - ≠ | II |
| 12) Rosenthal et al | Single-center | Chronic critical illness | This retrospective study aimed to document how chronic critical illness (CCI) patients (who received early, adequate nutrition per an established surgical ICU protocol) responds to adequate evidence-based ICU nutrition. | Function (physical activity) | 1) Functional status (Zubrod score) - ˅ | VI |
Notes: ˄Outcome improved after the intervention. ˅Outcome worsened after the intervention. ≠Outcome unchanged after the intervention. *Original Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients (EPaNIC) study41 and four sub-analyses of it.75–78
Abbreviations: LOE, level of evidence; N/A, not applicable (systematic reviews/meta-analyses); RCT, randomized control trial; ICU, intensive care unit; ICU-AW, intensive care unit-acquired weakness.